LAB compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

LABStandard Biotools Inc.

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

LABStandard Biotools Inc.

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

LABwithADPT

×0.36co-movement · ADPT on LAB · 500d

r 0.36scale to r 0.75

Shared co-movers2with LABwith ADPT

TXG10x Genomics, Inc.r 0.41r 0.47

PACBPacific Biosciences of California, Inc.r 0.37r 0.43

LAB, solidADPT, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

LABStandard Biotools Inc.

0.62▲+0.06%

Mkt cap$243.2MRevenue$19MQ3 FY26Revenue$65MFY25

ADPTAdaptive Biotechnologies Corp

26.03▼−2.53%

Regular sessionNov 5 '26

Mkt cap$4.3BRevenue$84MQ3 FY26Revenue$277MFY25

Compare

Regular sessionNov 5 '26

LABStandard Biotools Inc.

ADPTAdaptive Biotechnologies Corp

0.62▲+0.06%

Price

26.03▼−2.53%

$243.2M

Mkt cap

$4.3B

Q3 FY26$19M

Revenue

$84MQ3 FY26

FY25$65M

Revenue

$277MFY25

LAB0.62▲+0.06%vsADPT26.03▼−2.53%Regular sessionNov 5 '26